Abadan, Rogen P.

HRN: 21-32-28  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/09/2022
05/15/2022
IV
500mg
Q6 Hours
Post CS
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueIntra-abdominalReproductive Tract    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: